Timo Minssen

Timo Minssen

Professor

326 - 350 out of 413Page size: 25
  1. Lecture and oral contribution
  2. The CoNeXT project: Legal challenges in interdisciplinary settings, Danish Young Academy of Sciences

    Yu, H. (Speaker), Wested, Jakob (Speaker) & Minssen, Timo (Panel member)

    1 Nov 2017

    Activity: Talk or presentation typesLecture and oral contribution

  3. The Collaborative Research Programme in Biomedical Innovation Law (CeBIL)- Past, Presence & Future Visions

    Minssen, Timo (Invited speaker)

    9 Nov 2017

    Activity: Talk or presentation typesLecture and oral contribution

  4. The EPO’s plausibility approach and the industrial application requirement in biotech patenting

    Minssen, Timo (Lecturer)

    13 Aug 2012

    Activity: Talk or presentation typesLecture and oral contribution

  5. The European assessment of "inventive step"

    Minssen, Timo (Speaker)

    7 Feb 201511 Feb 2015

    Activity: Talk or presentation typesLecture and oral contribution

  6. The Importance of Social Sciences for a One Health Approach to Antimicrobial Resistance

    Minssen, Timo (Other)

    18 Aug 2020

    Activity: Talk or presentation typesLecture and oral contribution

  7. The Patent Governance of Genome Editing Technologies

    Minssen, Timo (Other)

    9 Jun 2022

    Activity: Talk or presentation typesLecture and oral contribution

  8. The Patent-Eligibility of Dosage Regimes and Diagnostic Methods in the U.S. & Europe

    Minssen, Timo (Speaker)

    13 Sep 2011

    Activity: Talk or presentation typesLecture and oral contribution

  9. The Proposed EU IP Exception for Generics & Biosimilars Exports - A Cure Worse Than the Disease? (at UC Irvine)

    Minssen, Timo (Invited speaker)

    8 Feb 2019

    Activity: Talk or presentation typesLecture and oral contribution

  10. The Scope of Protection for Biotech-Patents after Monsanto v. Cefetra

    Minssen, Timo (Speaker)

    8 Nov 2011

    Activity: Talk or presentation typesLecture and oral contribution

  11. The UPCA’s ”opt out” and “opt-in” provisions - Impact and strategies for European patent portfolios.

    Minssen, Timo (Lecturer)

    7 Oct 2014

    Activity: Talk or presentation typesLecture and oral contribution

  12. The US Supreme Court in FTC v. Actavis - Context, outcome & implications

    Minssen, Timo (Lecturer)

    18 Jun 2013

    Activity: Talk or presentation typesLecture and oral contribution

  13. The legal dimension of large European Research Infrastructures and the CoNext project

    Minssen, Timo (Speaker)

    31 Oct 2014

    Activity: Talk or presentation typesLecture and oral contribution

  14. The legal dimensions of Big Data: University of Copenhagen

    Minssen, Timo (Lecturer)

    20 May 2016

    Activity: Talk or presentation typesLecture and oral contribution

  15. The legal method of "Law & Technology"

    Minssen, Timo (Lecturer)

    6 Jun 2013

    Activity: Talk or presentation typesLecture and oral contribution

  16. The massive Impact of Brexit on Danish & UK life science corporations & collaborations

    Minssen, Timo (Invited speaker) & Bostyn, Sven (Invited speaker)

    10 Dec 2018

    Activity: Talk or presentation typesLecture and oral contribution

  17. The new Centre for Advanced Studies in Biomedical Innovation Law (CeBIL): Where we come from - What we do - Where we want to go.

    Minssen, Timo (Speaker) & Wested, Jakob (Speaker)

    25 May 2018

    Activity: Talk or presentation typesLecture and oral contribution

  18. The patent eligibility of human embryonic stem cell technology in Europe

    Minssen, Timo (Lecturer)

    13 Aug 2012

    Activity: Talk or presentation typesLecture and oral contribution

  19. The patent eligibility of human embryonic stem cell technology in Europe - What happened after Brüstle?

    Minssen, Timo (Lecturer)

    12 Aug 2013

    Activity: Talk or presentation typesLecture and oral contribution

  20. The patentability of personalized medicine in Europe - Dosage regimes and genetic diagnostic methods

    Minssen, Timo (Lecturer)

    13 Aug 2012

    Activity: Talk or presentation typesLecture and oral contribution

  21. U.S. regulation and patentability of human embryonic stem cell research

    Minssen, Timo (Speaker)

    21 Mar 2012

    Activity: Talk or presentation typesLecture and oral contribution

  22. US decisions in Sequenom Inc v Ariosa Diagnostics Inc- What now?: University of Cambridge (UK)

    Minssen, Timo (Invited speaker)

    6 Sep 2016

    Activity: Talk or presentation typesLecture and oral contribution

  23. Utility Model Protection in Danish Law at LSE

    Minssen, Timo (Other)

    2 Feb 2023

    Activity: Talk or presentation typesLecture and oral contribution

  24. WHO panel on the governance of gene editing

    Minssen, Timo (Other)

    2021

    Activity: Talk or presentation typesLecture and oral contribution

ID: 16150437